DiaMedica Therapeutics Inc. Common Stock
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DMAC and other ETFs, options, and stocks.About DMAC
DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD).
DMAC Key Statistics
Stock Snapshot
As of today, DiaMedica Therapeutics Inc. Common Stock(DMAC) shares are valued at $8.55. The company's market cap stands at 432.24M, with a P/E ratio of -11.59.
On 2025-12-19, DiaMedica Therapeutics Inc. Common Stock(DMAC) shares started trading at $8.47, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 636.54K.
Over the past 52 weeks, DiaMedica Therapeutics Inc. Common Stock(DMAC) stock has traded between a high of $10.42 and a low of $3.19.
Over the past 52 weeks, DiaMedica Therapeutics Inc. Common Stock(DMAC) stock has traded between a high of $10.42 and a low of $3.19.
DMAC News
DiaMedica Therapeutics (DMAC) announced the completion of a productive pre-IND meeting with the FDA for a planned study evaluating DM199 in preeclampsia. The co...
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...